1. Home
  2. Approved trials
  3. » فارسی

Examining the Impact of Fast Diet and Calorie Deficit Diet on Emerging Adipokines Lipocalin 2, Irisin, and Inflammatory Markers among Women with Obesity/Overweight: a Randomized Clinical Trial

View the latest revision

History
# Registration date Revision Id
2 2026-10-04, 1405/07/12 398411
1 2025-10-22, 1404/07/30 359958
Changes made to previous revision

  • Help:

    Red color represents old content. It may be empty showing addition in the new version.
    Green color represents new content. It may be empty showing deletion in the new version.

    Inline Side by side
    Added new contents, deleted old contents, contents that are not changed.
    New table contents New table contents
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    Added new contents, contents that are not changed.
    Deleted old contents, contents that are not changed.
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    New table contents New table contents
    Unchanged contents Unchanged contents

  • Protocol summary

    This is a randomized, controlled, parallel-group trial. Participants will be stratified using stratified randomization based on age and BMI. Then using the random numbers table are assigned to one of the two groups intervention and control. Because it is a diet intervention, it is not blinding. The trial phase is not applicable.
    This is a randomized, controlled, parallel-group trial. Participants will be stratified using stratified randomization based on age and BMI. Then using the random numbers table are assigned to one of the two groups intervention and control. Due to the dietary nature of the intervention, blinding is not feasible.However, Laboratory staff, the statistician, and the anthropometric assessor will be blinded to group allocation.The trial phase is not applicable.
    این یک کارآزمایی تصادفی، کنترل شده و گروهی موازی است. شرکت کنندگان با استفاده از تصادفی سازی طبقه ای بر اساس سن و BMI طبقه بندی خواهند شد. سپس با استفاده از جدول اعداد تصادفی به یکی از دو گروه مداخله و کنترل تخصیص داده می شوند. چون مداخله رژیم غذایی است، کورسازی ندارد. فاز کارآزمایی کاربرد ندارد.
    این یک کارآزمایی تصادفی، کنترل شده و گروهی موازی است. شرکت کنندگان با استفاده از تصادفی سازی طبقه ای بر اساس سن و BMI طبقه بندی خواهند شد. سپس با استفاده از جدول اعداد تصادفی به یکی از دو گروه مداخله و کنترل تخصیص داده می شوند.با توجه به ماهیت رژیمی مداخله، کورسازی امکان‌پذیر نیست. اما کارکنان آزمایشگاه، آنالیزور آماری و ارزیاب آنتروپومتریک نسبت به تخصیص گروهی کور خواهند بود.فاز کارآزمایی کاربرد ندارد.

  • General information

    empty
    47
    empty
    2026-03-21, 1405/01/01
    empty
    2026-07-21, 1405/04/30
    empty
    The study information was updated to clarify and complete the registered protocol details.
    empty
    اطلاعات مطالعه به منظور شفاف‌سازی و تکمیل جزئیات پروتکل ثبت‌شده به‌روزرسانی شد.

  • Primary outcomes

    #1
    Body Mass Index
    Waist circumference
    شاخص توده بدنی
    دور کمر
    Height: stadiometer, Weight: scale
    using nonstretchable (flexible) tape measure
    قد : استادیومتر، وزن: ترازو
    متر نواری غیر قابل ارتجاع
    #2
    waist-hip ratio
    empty
    نسبت کمر به باسن
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    standard formula
    empty
    فرمولای استاندارد
    empty
    #3
    visceral fat area
    empty
    ناحیه چربی احشایی
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    standard formula
    empty
    فرمولای استاندارد
    empty
    #4
    body fat percentage
    empty
    درصد چربی بدن
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    standard formula
    empty
    فرمولای استاندارد
    empty
    #5
    Waist circumference
    empty
    دور کمر
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    using nonstretchable (flexible) tape measure
    empty
    متر نواری غیر قابل ارتجاع
    empty
    #6
    Hip circumference
    empty
    دور باسن
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    using nonstretchable (flexible) tape measure
    empty
    متر نواری غیر قابل ارتجاع
    empty
    #7
    C-reactive protein
    empty
    پروتِیِن واکنشگرC
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    ELISA Method
    empty
    روش ELISA
    empty
    #8
    interleukin-1
    empty
    اینترلوکین1
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    ELISA method
    empty
    روش ELISA
    empty
    #9
    Monocyte chemoattractant protein-1
    empty
    پروتئین جاذب شیمیایی مونوسیت-۱
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    ELISA method
    empty
    روش ELISA
    empty
    #10
    irisin
    empty
    آیریزین
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    ELISA method
    empty
    روش ELISA
    empty
    #11
    lipocalin 2
    empty
    لیپوکالین2
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    ELISA method
    empty
    روش ELISA
    empty
    #12
    Alanine Aminotransferase
    empty
    آلانین آمینوترانسفراز
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    SGPT
    empty
    آزمایش ترانس آمیناز گلوماتیک – پیرویک سرم
    empty
    #13
    AST
    empty
    آسپارتات آمینوترانسفراز
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    SGOT
    empty
    گلوتامیک اگزالواستیک ترانس‌آمیناز
    empty
    #14
    waist-to-hip ratio
    empty
    نسبت دور کمر به دور باسن
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    Standard method
    empty
    فرمول استاندارد
    empty

  • Secondary outcomes

    #1
    empty
    Body Mass Index
    empty
    شاخص توده بدنی
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    Height: stadiometer, Weight: scale
    empty
    قد : استادیومتر، وزن: ترازو
    #2
    empty
    waist-hip ratio
    empty
    نسبت کمر به باسن
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    standard formula
    empty
    فرمولای استاندارد
    #3
    empty
    visceral fat area
    empty
    ناحیه چربی احشایی
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    standard formula
    empty
    فرمولای استاندارد
    #4
    empty
    body fat percentage
    empty
    درصد چربی بدن
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    standard formula
    empty
    فرمولای استاندارد
    #5
    empty
    Hip circumference
    empty
    دور باسن
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    using nonstretchable (flexible) tape measure
    empty
    متر نواری غیر قابل ارتجاع
    #6
    empty
    C-reactive protein
    empty
    پروتِیِن واکنشگرC
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    Pars Azmoon commercial kit
    empty
    کیت تجاری شرکت پارس‌آزمون
    #7
    empty
    interleukin-1
    empty
    اینترلوکین1
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    ELISA method
    empty
    روش ELISA
    #8
    empty
    Monocyte chemoattractant protein-1
    empty
    پروتئین جاذب شیمیایی مونوسیت-۱
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    ELISA method
    empty
    روش ELISA
    #9
    empty
    irisin
    empty
    آیریزین
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    ELISA method
    empty
    روش ELISA
    #10
    empty
    lipocalin 2
    empty
    لیپوکالین2
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    ELISA method
    empty
    روش ELISA
    #11
    empty
    Alanine Aminotransferase
    empty
    آلانین آمینوترانسفراز
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    SGPT
    empty
    آزمایش ترانس آمیناز گلوماتیک – پیرویک سرم
    #12
    empty
    AST
    empty
    آسپارتات آمینوترانسفراز
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    SGOT
    empty
    گلوتامیک اگزالواستیک ترانس‌آمیناز
    #13
    empty
    waist-to-hip ratio
    empty
    نسبت دور کمر به دور باسن
    empty
    The beginning and end of the study
    empty
    ابتدا و انتهای مطالعه
    empty
    standard formula
    empty
    فرمولای استاندارد

  • Recruitment centers

    #1
    Name of recruitment center - English: Kashan Health Centers
    Name of recruitment center - Persian: مراکز بهداشت کاشان
    Full name of responsible person - English: Sadegh Jafarnejad
    Full name of responsible person - Persian: صادق جعفرنژاد
    Street address - English: کیلومتر پنجم بلوار قطب راوندی
    Street address - Persian: 5th of Qotb –e Ravandi Blvd.
    City - English: Kashan
    City - Persian: کاشان
    Province: Isfehan
    Country: Iran (Islamic Republic of)
    Postal code: 8715973474
    Phone: +98 21 5544 7275
    Fax: +98 21 5544 2061
    Email: darman@at_kaums.ac.ir
    Web page address: http://contact.kaums.ac.ir/Default.aspx
    Name of recruitment center - English: Kashan Health Centers
    Name of recruitment center - Persian: مراکز بهداشت کاشان
    Full name of responsible person - English: Sadegh Jafarnejad
    Full name of responsible person - Persian: صادق جعفرنژاد
    Street address - English: کیلومتر پنجم بلوار قطب راوندی
    Street address - Persian: 5th of Qotb –e Ravandi Blvd.
    City - English: Kashan
    City - Persian: کاشان
    Province: Isfehan
    Country: Iran (Islamic Republic of)
    Postal code: 8715973474
    Phone: +98 21 5544 7275
    Fax: +98 21 5544 2061
    Email: drsadegh2008@gmail.com
    Web page address: http://contact.kaums.ac.ir/Default.aspx

  • Sponsors / Funding sources

    #1

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Sadegh Jafarnejad
    Full name of responsible person - Persian: صادق جعفرنژاد
    Street address - English: کیلومتر پنجم بلوار قطب راوندی
    Street address - Persian: 5th of Qotb –e Ravandi Blvd.
    City - English: Kashan
    City - Persian: کاشان
    Province: Isfehan
    Country: Iran (Islamic Republic of)
    Postal code: 8715988141
    Phone: +98 31 5554 1112
    Fax: +98 31 5554 1112
    Email: banafshe57@hotmail.com
    Web page address: http://en.kaums.ac.ir/Default.aspx?PageID=199
    contact.organization_id:
    Name of organization / entity - English: National Institute for Medical Research Development(NIMAD)
    Name of organization / entity - Persian: مؤسسه ملی توسعه تحقیقات علوم پزشکی جمهوری اسلامی ایران (نیماد)
    Full name of responsible person - English: Sadegh Jafarnejad
    Full name of responsible person - Persian: صادق جعفرنژاد
    Street address - English: کیلومتر پنجم بلوار قطب راوندی
    Street address - Persian: 5th of Qotb –e Ravandi Blvd.
    City - English: Kashan
    City - Persian: کاشان
    Province: Isfehan
    Country: Iran (Islamic Republic of)
    Postal code: 8715988141
    Phone: +98 31 5554 1112
    Fax: +98 31 5554 1112
    Email: banafshe57@hotmail.com
    Web page address: http://en.kaums.ac.ir/Default.aspx?PageID=199
    Kashan University of Medical Sciences
    National Institute for Medical Research Development(NIMAD)
    دانشگاه علوم پزشکی کاشان
    مؤسسه ملی توسعه تحقیقات علوم پزشکی جمهوری اسلامی ایران (نیماد)

Protocol summary

Study aim
Examining the Impact of Fast Diet and Calorie Deficit Diet on Emerging Adipokines Lipocalin 2, Irisin, and Inflammatory Markers among Women with Obesity/Overweight
Design
This is a randomized, controlled, parallel-group trial. Participants will be stratified using stratified randomization based on age and BMI. Then using the random numbers table are assigned to one of the two groups intervention and control. Due to the dietary nature of the intervention, blinding is not feasible.However, Laboratory staff, the statistician, and the anthropometric assessor will be blinded to group allocation.The trial phase is not applicable.
Settings and conduct
Participants are selected from the Health Centers of Kashan University of Medical Sciences by convenient sampling. Participants are randomly assigned into two groups.
Participants/Inclusion and exclusion criteria
Inclusion Criteria: Women aged 18–50 years with BMI 25–40 kg/m², not following specific diets or using weight-loss medications/supplements, without chronic or psychological illnesses, and not pregnant or breastfeeding. Exclusion Criteria: Those with hypertension, diabetes, heart, or gastrointestinal diseases; smokers; individuals with eating disorders; or those non-adherent or lost to follow-up.
Intervention groups
Participants will adhere to a prescribed diet for 12 weeks, tailored to their group and daily energy requirements, which are calculated using the Mifflin equation. The FD diet (5:2 intermittent fasting protocol) involves two fasting days per week, during which participants consume only 25% of their recommended caloric intake, and five feeding days, where they consume 100% of their calculated daily energy requirements and follow these dietary plans for 12 weeks.
Main outcome variables
BMI, waist-hip ratio, visceral fat area, body fat percentage, Waist circumference, C-reactive protein , interleukin-1, MCP-1, irisin, lipocalin 2

General information

Reason for update
The study information was updated to clarify and complete the registered protocol details.
Acronym
IRCT registration information
IRCT registration number: IRCT20220522054958N4
Registration date: 2025-10-22, 1404/07/30
Registration timing: prospective

Last update: 2026-10-06, 1405/07/14
Update count: 1
Registration date
2025-10-22, 1404/07/30
Registrant information
Name
Saeedeh Hosseini hooshiar
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 31 5558 9024
Email address
shoseinih3322@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2026-03-21, 1405/01/01
Expected recruitment end date
2027-03-21, 1406/01/01
Actual recruitment start date
2026-03-21, 1405/01/01
Actual recruitment end date
2026-07-21, 1405/04/30
Trial completion date
empty
Scientific title
Examining the Impact of Fast Diet and Calorie Deficit Diet on Emerging Adipokines Lipocalin 2, Irisin, and Inflammatory Markers among Women with Obesity/Overweight: a Randomized Clinical Trial
Public title
The Impact of Fast Diet on Lipocalin 2, Irisin, and Inflammatory Markers
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
The study will focus exclusively on women aged 18 to 50 to eliminate potential confounding factors related to sex-based differences in hormonal profiles, body composition, and metabolic responses to dietary interventions. This age range focuses on women during their reproductive years and excludes women undergoing significant menopausal transitions (as stated in the proposal's rationale). BMI (25-40 kg/m2): Participants will have a BMI ranging from 25 to 40 kg/m2. This BMI range ensures that all participants meet the criteria for overweight or obesity, as defined by the World Health Organization (WHO). Absence of Specific Diets/Weight Loss Medications/Supplements: Participants should not be following a specific diet or taking weight loss medications, and should not be consuming dietary supplements for weight loss. This ensures that the observed effects are attributable to the assigned dietary intervention (FD or CR) and not influenced by pre-existing dietary habits or pharmacological interventions. Absence of History of Chronic Illnesses: Absence of a history of chronic illnesses such as heart disease, hypertension, diabetes, and gastrointestinal disorders. Absence of Mental or Psychological Illnesses: Participants should be free from any mental or psychological illnesses. Not Pregnant or Breastfeeding: Participants should not be pregnant or breastfeeding. Participants are required to adhere to the prescribed caloric intake, with total caloric intake falling below 80% or exceeding 110% of the recommended amount.
Exclusion criteria:
Patients who may be diagnosed with hypertension, diabetes, heart disease, or gastrointestinal disorders during the study will be excluded to maintain the homogeneity of the study population and to prevent the confounding influence of newly developed health conditions on the study outcomes. Individuals who do not adhere to the prescribed caloric intake (defined as total caloric intake falling below 80% or exceeding 110% of the recommended amount) will be excluded due to the potential for this to compromise the integrity of the intervention and the validity of the results. Lost to Follow-Up/Unwilling to Continue: Participants who are lost to follow-up and are unwilling to continue the study will be excluded as they cannot provide complete data for analysis. Smoking has a profound impact on inflammation, oxidative stress, and metabolic function. To avoid confounding effects related to smoking, current smokers will be excluded. Individuals with a history of eating disorders (e.g., anorexia nervosa, bulimia nervosa) will be excluded due to the potential for these conditions to influence adherence to the dietary interventions and to confound the psychological and physiological outcomes of the study.
Age
From 18 years old to 50 years old
Gender
Female
Phase
1
Groups that have been masked
No information
Sample size
Target sample size: 50
Actual sample size reached: 47
Randomization (investigator's opinion)
Randomized
Randomization description
Participants will undergo stratified randomization based on BMI (classified into two categories: 40 > BMI ≥ 30 and 30 > BMI ≥ 25) and age (classified into two categories: 50 > age ≥ 30 and 30 > age ≥ 18). Each subject will be ranked according to their age and BMI to ensure greater homogeneity between groups. Following this ranking, individuals will be assigned to either the control or intervention group using a random numbers table. Due to the nature of the intervention, blinding of participants to their group allocation is not feasible. An independent statistician, who remains blinded throughout the study, will generate the allocation sequences using a random numbers table.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Used
Assignment
Parallel
Other design features
All participants will provide informed consent before entering the study. A physician and a trained nutritionist will thoroughly evaluate and inform the patients about the study's methodology, and written consent will be obtained. Demographic information will be collected using a questionnaire, and anthropometric measurements, such as BMI, waist-hip ratio, visceral fat area, body fat percentage, Waist circumference (WC), Hip circumference (HC), Mid-upper arm circumference (MUAC) and Forearm and calf circumference, will be recorded. The participants will then be randomized into either the intervention or control group using a random numbers table. Each individual will be assigned to either Group A, which follows the Fast Diet, or Group B, which follows the Calorie Deficit Diet. Prior to the intervention, a 20 cc blood sample will be collected from each participant to measure biochemical, adipokines, and inflammatory indices.

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Faculty of Medicine and Dentistry - Kashan University of Medical Sciences (Research Ethics Committee
Street address
5 km Qutb Ravandi Boulevard, Kashan University of Medical Sciences, Vice Chancellor for Research
City
Kashan
Province
Isfehan
Postal code
8715988141
Approval date
2025-05-04, 1404/02/14
Ethics committee reference number
IR.NIMAD.REC.1404.028

Health conditions studied

1

Description of health condition studied
Obesity or overweight
ICD-10 code
ICD-10 code description

Primary outcomes

1

Description
Waist circumference
Timepoint
The beginning and end of the study
Method of measurement
using nonstretchable (flexible) tape measure

Secondary outcomes

1

Description
Mid-upper arm circumference
Timepoint
The beginning and end of the study
Method of measurement
Non-elastic tape measure

2

Description
Forearm circumference
Timepoint
The beginning and end of the study
Method of measurement
Non-elastic tape measure

3

Description
calf circumference
Timepoint
The beginning and end of the study
Method of measurement
Non-elastic tape measure

4

Description
total cholesterol
Timepoint
The beginning and end of the study
Method of measurement
Enzymatic method

5

Description
triglycerides
Timepoint
The beginning and end of the study
Method of measurement
Triglyceride oxidase

6

Description
high-density lipoprotein
Timepoint
The beginning and end of the study
Method of measurement
Fasting blood HDL cholesterol is measured in the laboratory.

7

Description
low-density lipoprotein
Timepoint
The beginning and end of the study
Method of measurement
Fasting blood LDL cholesterol is measured in the laboratory.

8

Description
fasting plasma glucose
Timepoint
The beginning and end of the study
Method of measurement
The fasting blood Glucose level determined in laboratory

9

Description
Body Mass Index
Timepoint
The beginning and end of the study
Method of measurement
Height: stadiometer, Weight: scale

10

Description
waist-hip ratio
Timepoint
The beginning and end of the study
Method of measurement
standard formula

11

Description
visceral fat area
Timepoint
The beginning and end of the study
Method of measurement
standard formula

12

Description
body fat percentage
Timepoint
The beginning and end of the study
Method of measurement
standard formula

13

Description
Hip circumference
Timepoint
The beginning and end of the study
Method of measurement
using nonstretchable (flexible) tape measure

14

Description
C-reactive protein
Timepoint
The beginning and end of the study
Method of measurement
Pars Azmoon commercial kit

15

Description
interleukin-1
Timepoint
The beginning and end of the study
Method of measurement
ELISA method

16

Description
Monocyte chemoattractant protein-1
Timepoint
The beginning and end of the study
Method of measurement
ELISA method

17

Description
irisin
Timepoint
The beginning and end of the study
Method of measurement
ELISA method

18

Description
lipocalin 2
Timepoint
The beginning and end of the study
Method of measurement
ELISA method

19

Description
Alanine Aminotransferase
Timepoint
The beginning and end of the study
Method of measurement
SGPT

20

Description
AST
Timepoint
The beginning and end of the study
Method of measurement
SGOT

21

Description
waist-to-hip ratio
Timepoint
The beginning and end of the study
Method of measurement
standard formula

Intervention groups

1

Description
Participants will adhere to a prescribed diet for 12 weeks, tailored to their group and daily energy requirements, which are calculated using the Mifflin equation. The FD diet (5:2 intermittent fasting protocol) involves two fasting days per week, during which participants consume only 25% of their recommended caloric intake, and five feeding days, where they consume 100% of their calculated daily energy requirements across three main meals and three snacks. Feeding times are standardized: breakfast at 8:00, lunch at 13:00, dinner at 20:00, with snacks at 10:00, 16:00, and 22:00. The control group consumes 80% of their daily energy requirement with the same meal and snack schedule. Both groups follow these dietary plans for 12 weeks, with daily macronutrient distribution set at 55% carbohydrates, 30% fat, and 15% protein. Participants are monitored for any adverse effects, which are reported to the research staff, and no physical or psychological harm is anticipated from the study.
Category
Prevention

Recruitment centers

1

Recruitment center
Name of recruitment center
Kashan Health Centers
Full name of responsible person
Sadegh Jafarnejad
Street address
کیلومتر پنجم بلوار قطب راوندی
City
Kashan
Province
Isfehan
Postal code
8715973474
Phone
+98 21 5544 7275
Fax
+98 21 5544 2061
Email
drsadegh2008@gmail.com
Web page address
http://contact.kaums.ac.ir/Default.aspx

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
National Institute for Medical Research Development(NIMAD)
Full name of responsible person
Sadegh Jafarnejad
Street address
کیلومتر پنجم بلوار قطب راوندی
City
Kashan
Province
Isfehan
Postal code
8715988141
Phone
+98 31 5554 1112
Fax
+98 31 5554 1112
Email
banafshe57@hotmail.com
Web page address
http://en.kaums.ac.ir/Default.aspx?PageID=199
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
National Institute for Medical Research Development(NIMAD)
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Sadegh Jafarnejad
Position
Associate Professor
Latest degree
Medical doctor
Other areas of specialty/work
Nutrition
Street address
5th of Qotb –e Ravandi Blvd.
City
Kashan
Province
Isfehan
Postal code
8715988141
Phone
+98 31 5554 1112
Fax
+98 31 5554 1112
Email
drsadegh2008@gmail.com
Web page address
http://en.kaums.ac.ir/Default.aspx?PageID=199

Person responsible for scientific inquiries

Contact
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Sadegh Jafarnejad
Position
Associate Professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
5th of Qotb –e Ravandi Blvd.
City
Kashan
Province
Isfehan
Postal code
8715988141
Phone
+98 31 5554 1112
Fax
+98 31 5554 1112
Email
drsadegh2008@gmail.com
Web page address
http://en.kaums.ac.ir/Default.aspx?PageID=199

Person responsible for updating data

Contact
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Saeedeh Hosseini Hooshiar
Position
PhD student
Latest degree
Master
Other areas of specialty/work
Nutrition
Street address
5th of Qotb –e Ravandi Blvd.
City
Kashan
Province
Isfehan
Postal code
8715988141
Phone
+98 31 5554 1112
Email
shoseinih3322@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
All data can be shared after making participants anonymous.
When the data will become available and for how long
Six months after publishing results, everything will be accessible.
To whom data/document is available
The data from this research will be accessible only to health researchers and those who are working in academic and scientific institutions
Under which criteria data/document could be used
With respect to ethical considerations, the data from this research can be used for other research purposes. It is also possible to conduct any statistical analyses. All these processes require correspondence and coordination.
From where data/document is obtainable
All applicants can contact Dr. Sadegh Jafarnejad through e-mail drsadegh2008@gmail.com
What processes are involved for a request to access data/document
Within 10 working days after correspondence or a phone call, your request will be answered and the data will be sent to a valid email submitted by the applicant.
Comments
Loading...